Related Experiment Video
Updated: Sep 22, 2025
08:49
Murine Prostate Micro-dissection and Surgical Castration
Published on: May 11, 2016
46.1K
The MNU Plus Testosterone Rat Model of Prostate Carcinogenesis
Maarten C Bosland1, Michael J Schlicht1, Lori Horton2
1University of Illinois at Chicago, Chicago, Illinois, USA.
Toxicologic Pathology
|May 19, 2022
Summary
The N-methyl-N-nitrosourea (MNU) plus testosterone rat model reliably mimics human prostate cancer. This robust and reproducible model aids in identifying effective chemopreventive treatments for this common male cancer.
Area of Science:
- Oncology
- Carcinogenesis
- Animal Models
Background:
- Prostate cancer is a significant male malignancy requiring effective chemoprevention.
- Animal models are crucial for evaluating potential treatments.
- The N-methyl-N-nitrosourea (MNU) plus testosterone rat model is a well-established tool.
Purpose of the Study:
- To detail the induction protocol for the MNU plus testosterone rat model.
- To demonstrate the model's robustness, reproducibility, and diagnostic criteria.
- To enable reliable use of this model for prostate cancer research.
Main Methods:
- Induction of prostate carcinogenesis using N-methyl-N-nitrosourea (MNU) and testosterone.
- Utilizing Wistar WU and Fischer F344 rat strains for high tumor incidence.
- Long-term, low-dose testosterone administration.
Main Results:
- The MNU plus testosterone model accurately recapitulates human prostate cancer.
- Adenocarcinomas primarily develop in the anterior and dorsolateral prostate, with metastasis.
- High tumor incidence is achieved with specific rat strains and testosterone treatment.
Conclusions:
- The MNU plus testosterone rat model is a robust and reproducible tool for prostate cancer chemoprevention studies.
- The model demonstrates good predictive value for human clinical trial outcomes.
- Understanding the protocol is key for consistent and reliable research findings.
